Generated by AI
Azenta, Inc. is a life sciences tools and services company focused on sample management, biostorage, and genomic services. The company provides automated storage systems, temperature-controlled logistics, laboratory consumables, informatics, and repository services that help customers preserve, track, and manage biological and chemical samples across research, clinical development, and commercialization workflows. Azenta also offers sequencing, gene synthesis, and related multiomics services for pharmaceutical, biotechnology, academic, and healthcare customers. Its solutions are used to support drug development, clinical research, advanced therapies, and biospecimen handling, making the company an important provider of infrastructure for sample integrity and data-driven life sciences operations. Azenta is headquartered in Burlington, Massachusetts, and serves a global customer base across North America, Europe, and Asia.
Website200 Summit Drive
Burlington, MA, 01803
United States
The latest articles about AZTA.
Detailed price information for Coinbase Global Cl A (COIN-Q) from The Globe and Mail including charting and trades.
Azenta shares fall 7.4% after its fiscal Q4 call; revenue rises 5% to $167 million, while Multiomics organic sales decline 1%.
Its final earnings report for fiscal 2026 was impressive.
Summary of Jul 1's posts. Generated by AI.
Summary of Nov 15's posts. Generated by AI.
Summary of Nov 21's posts. Generated by AI.
Investors talking about AZTA also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.